PUBLISHED RESEARCH
Shin A, Camilleri M, Busciglio I, Burton D, Smith SA, Vella A, Ryks M, Rhoten D, Zinsmeister AR.
The Ghrelin Agonist RM-131 Accelerates Gastric Emptying of Solids and Reduces Symptoms in Patients with Type 1 Diabetes Mellitus. Clin Gastroenterol Hepatol. 2013 Apr 29 [Epub ahead of print]. PubMed PMID: 23639598. doi: 10.1016/j.cgh.2013.04.019.
Kievit P, Halem H, Marks DL, Dong JZ, Glavas MM, Sinnayah P, Pranger L, Cowley MA, Grove KL, Culler MD.
Chronic Treatment With a Melanocortin 4 Receptor Agonist Causes Weight Loss, Reduces Insulin Resistance, and Improves Cardiovascular Function in Diet-Induced Obese Rhesus Macaques.
Diabetes. 2012 Oct 9 [Epub ahead of print]. doi:10.2337/db12-0598.
Shin A, Camilleri M, Busciglio I, Burton D, Stoner E, Noonan P, Gottesdiener K, Smith SA, Vella A, Zinsmeister AR.
Randomized Controlled Phase Ib Study of Ghrelin Agonist, RM-131, in Type 2 Diabetic Women With Delayed Gastric Emptying: Pharmacokinetics and pharmacodynamics. Diabetes Care. 2012 Sep 6 [Epub ahead of print]. PubMed PMID: 22961573. doi: 10.2337/dc12-1128.
Datta R, Soulard C, Teillot M, Touvay C, Halem H, Dong J, Culler M.
RM-131: A Potent Gastroprokinetic Agent. Digestive Disease Week, May 7, 2011.